Skip to main content

Table 3 Headache-associated disability scores pre- and post- treatment with OnabotulinumtoxinA

From: OnabotulinumtoxinA in the treatment of refractory chronic cluster headache

 

HIT- 6 (36–76)

HADS - A (0–21)

HADS - D (0–21)

patients ID

pre

w 24

change in score

pre

w 24

change in score

pre

w 24

change in score

1

70

50

20

18

15

3

8

6

2

2

58

36

22

15

9

6

12

8

4

3

67

47

20

17

15

2

15

12

3

4

76

42

34

15

6

9

6

3

3

5

78

58

20

15

12

3

9

4

5

6

58

52

6

11

8

3

10

3

7

7

63

58

5

13

11

2

10

7

3

8

63

42

21

13

12

1

8

2

6

9

57

42

13

12

11

1

12

11

1

10

78

68

10

11

12

-1

11

9

2

11

65

68

−3

13

15

−2

14

15

−1

12

68

57

11

11

12

−1

11

5

6

13

65

65

0

18

21

−3

16

16

0

14

56

36

20

12

6

6

4

0

4

15

53

57

−4

14

12

2

15

12

3

16

68

54

14

14

9

5

12

9

3

17

76

72

4

12

11

1

14

11

3

Mean (95% CI)

65.8

53.1

−12.7 (−21.3; −1.8)

13.8

11.6

−2.2 (−6.1; −0.1)

11.0

7.8

−3.2 (−8.2; −0.1)

median (range)

65 (53–78)

54 (36–72)

13 (− 3–34)

13 (11–18)

12 (6–21)

2 (− 2–9)

11 (6–16)

8 (0–16)

3 (− 1–7)

  1. pre = before treatment (=baseline), w = week; HIT-6 = Headache Impact Test, HADS=Hospital Anxiety and Depression Scale, A = anxiety, D = depression